Antigen-based Immunotherapy Improves Glycemic Metrics and β-Cell Function

J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4250-e4251. doi: 10.1210/clinem/dgac437.
No abstract available

Keywords: CGM; immunotherapy; β-cell.

Publication types

  • Comment

MeSH terms

  • Alum Compounds
  • Benchmarking
  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • Diabetes Mellitus, Type 1* / therapy
  • Glycemic Control
  • HLA-DR3 Antigen
  • Humans
  • Immunotherapy

Substances

  • Alum Compounds
  • Blood Glucose
  • HLA-DR3 Antigen
  • aluminum sulfate